Guggenheim Securities adjusted its price target for Immunovant shares, listed on (NASDAQ:IMVT), to $44.00, a decrease from the previous $46.00, while sustaining a Buy rating on the stock. Currently ...

The U.S. health-care system exchanges tens of millions of patient records a day. Thanks to recent technological advances, the ability to analyze such large amounts of data has improved markedly.

Scientists, researchers and private health organizations scrambled to preserve as much federal public health data and ...

We recently compiled a list of the 12 Best Healthcare Stocks to Buy According to Analysts. In this article, we are going to ...

The American Cancer Society is calling on the Trump administration to restore access to comprehensive scientific data.

It’s no secret that cloud adoption continues to grow in healthcare, evolving from a nice-to-have feature to an essential part of operations for at least 80% of organizations.

Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the ...

Every technological revolution has a defining moment when a specific use case propels the technology into widespread adoption. That time has come for generative AI (GenAI) with the rapid spread of ...

CenExel, a leading network of clinical research sites, proudly congratulates and announces its role in supporting Vertex Pharmaceuticals’ clinical studies that led to the FDA approval of JOURNAVX™ ...

In this modern era, where artificial intelligence is reshaping industries, healthcare is witnessing a profound transformation ...

While some information has been restored, scientists are still alarmed over the removal of data. It's not clear what has ...

YPrime has announced the launch of its Automated Data Change Form (DCF), an innovative feature within the latest release of ...